EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a Tool to Assess the Severity of Pulmonary Hypertension in Patients with Interstitial Lung Disease: A Guide to Assist Therapeutic Choices

Garrett Fiscus iD, Chebly Dagher iD, David O'Sullivan, Brett Carollo, Kristen Swanson, Harrison W Farber, Raj Parikh

Advances in Respiratory Medicine · 2025

DOI: 10.3390/arm93050041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Respiratory Medicine, 2025. Verfasst von Garrett Fiscus und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care and Sleep, Hartford Hospital, Hartford, CT 06106, USA. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Hypertension, Pulmonary, Severity of Illness Index. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pulmonary hypertension (PH) is a frequent complication in patients with interstitial lung disease (ILD); its occurrence results in significant morbidity and mortality. Currently approved treatment options for PH-ILD include inhaled prostacyclin therapy, although this approach may be insufficient in patients who have developed simultaneous right ventricular failure. Moreover, there is no available treatment algorithm regarding the optimal therapy and timing of lung transplant referral for PH-ILD patients based on disease severity. Design/Methods: In this study, we created such a tool to guide PH-specific therapy in PH-ILD patients, especially as further treatment strategies are developed. We developed a 4-point PH-ILD Severity score that integrated both subjective and objective information (WHO FC, CI, TAPSE, PVR) from retrospective analysis of 57 PH-ILD patients.

Results

A score of 3 or greater in the PH-ILD Severity score yielded an AUC of 0.831 (p < 0.001) for the composite endpoint of clinical worsening (hospitalization due to a cardiopulmonary indication; decrease in 6 min walk distance by >15% at 2 consecutive visits; all-cause mortality; lung transplantation).

Conclusions

Further confirmation and evolution of this PH-ILD Severity score will assist in the development of optimal treatment plans in ILD patients diagnosed with concomitant PH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung Diseases, InterstitialHypertension, PulmonarySeverity of Illness IndexHumansFemaleMaleRetrospective StudiesMiddle AgedAgedLung Transplantation

Stichwörter der Autor:innen

interstitial lung diseaselung transplantpulmonary hypertension

Autor:innen und Institutionen

  • Division of Pulmonary, Critical Care and Sleep, Hartford Hospital, Hartford, CT 06106, USA.
  • Division of Internal Medicine, University of Connecticut, Farmington, CT 06030, USA.
  • Department of Research Administration, Hartford HealthCare, Hartford, CT 06106, USA.
  • Division of Pulmonary, Sleep and Critical Care Medicine, Tufts Medical Center, Boston, MA 02111, USA.

ORCID-Profile: Garrett Fiscus, Chebly Dagher

Zitieren

APA

Fiscus, G., Dagher, C., O'Sullivan, D., Carollo, B., Swanson, K., Farber, H. W., & Parikh, R. (2025). Development of a Tool to Assess the Severity of Pulmonary Hypertension in Patients with Interstitial Lung Disease: A Guide to Assist Therapeutic Choices. Advances in Respiratory Medicine. https://doi.org/10.3390/arm93050041

Vancouver

Fiscus G, Dagher C, O'Sullivan D, Carollo B, Swanson K, Farber HW, et al. Development of a Tool to Assess the Severity of Pulmonary Hypertension in Patients with Interstitial Lung Disease: A Guide to Assist Therapeutic Choices. Advances in Respiratory Medicine. 2025. doi:10.3390/arm93050041

BibTeX
@article{Fiscus2025,
  author = {Fiscus, Garrett and Dagher, Chebly and O'Sullivan, David and Carollo, Brett and Swanson, Kristen and Farber, Harrison W and Parikh, Raj},
  title = {Development of a Tool to Assess the Severity of Pulmonary Hypertension in Patients with Interstitial Lung Disease: A Guide to Assist Therapeutic Choices},
  journal = {Advances in Respiratory Medicine},
  year = {2025},
  doi = {10.3390/arm93050041}
}
Kostenlos starten →